Description
Developer of cardiovascular drug. The company is engaged in drug discovery for cardiovascular related fields. It has development programs targeting clotting disorders, hypertension and diabetes.
Contact Information
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2012336036-A1 | An extended release formulation of a direct thrombin inhibitor | Inactive | 07-Nov-2011 | 0000000000 | |
CA-2857953-A1 | An extended release formulation of a direct thrombin inhibitor | Inactive | 07-Nov-2011 | 0000000000 | |
EP-2780016-A1 | An extended release formulation of a direct thrombin inhibitor | Inactive | 07-Nov-2011 | 0000000000 | |
EP-2780016-A4 | An extended release formulation of a direct thrombin inhibitor | Inactive | 07-Nov-2011 | 0000000000 | |
US-20140309239-A1 | Extended release formulation of a direct thrombin inhibitor | Active | 07-Nov-2011 | A61K31/497 |